Analytical Data
-
基因名
GRA6
- 应用
-
别名
Antigen p32 (Protein p33)
-
种属
TOV-Toxoplasma gondii
-
表达系统
E. coli
-
标签
N- GST
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q27003
-
表达区间
35-150aa
-
分子量
38.6 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
GRA6, a protein encoded by the Toxoplasma gondii genome, is classified as a dense granule protein and plays a crucial role in the parasite's interaction with host cells. Research on GRA6 has gained significant attention due to its potential implications in understanding the biology of T. gondii, a major intracellular parasite responsible for toxoplasmosis, a disease affecting millions worldwide. This protein is secreted into the host cell cytosol during the invasion and is implicated in modulating host immune responses. Studies suggest that GRA6 can interact with various host cell proteins, potentially altering signaling pathways and enabling the parasite to evade host defenses. Understanding the structure and function of GRA6 is essential for developing new therapeutic strategies and vaccines against T. gondii. Moreover, the insights gained from GRA6 may offer broader implications for other apicomplexan parasites, highlighting its relevance in parasitology and immunology research. As a key player in the pathogenesis of toxoplasmosis, elucidating the mechanisms by which GRA6 contributes to the parasite's survival and manipulation of host cellular processes remains a pivotal area of investigation.
